ARCHIVES

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Salmon Enthusiastic About Comprehensive Core Grant Plan

May 6, 1988

FDA Approves Afinitor For pNET; No Word On Sutent For Same Use

May 6, 2011

NCI To Fund Partnerships Between Cancer Centers and Minority Institutions

November 12, 1999

In Brief: Bishop No Longer Candidate For NCI Director; HHS Endorses Intramural Scientist Klausner

April 21, 1995

Children’s Oncology Group to Select New Chairman; Four Leaders to Step Aside

April 28, 2000

“Great Charlie Moertel Shootout: In Tucson Draws Laughs, Criticism

April 17, 1981